ras Genes and Human Cancer: Different Implications and Different Roles
Journal:
Current Genomics
Volume:
3
Page:
295-311
Author(s):
Jose M. Rojas and Eugenio Santos
Genetics of Cancer Susceptibility
Journal:
Current Genomics
Volume:
3
Page:
379-388
Author(s):
Rogelio Gonzalez-Sarmiento
The Use of Computational Methods in the Discovery and Design of Kinase Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1527-1545
Author(s):
John R. Woolfrey and G. Scott Weston
Anthrax Fusion Protein Therapy of Cancer
Journal:
Current Protein & Peptide Science
Volume:
3
Page:
399-407
Author(s):
Arthur E. Frankel, Bayard L. Powell, Nick S. Duesbery, George F. Vande Woude and Stephen H. Leppla
Pharmacological Strategies to Increase the Antitumor Activity of Methylating Agents
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
1285-1301
Author(s):
Lucio Tentori and Grazia Graziani
Green Tea Catechins as Novel Antitumor and Antiangiogenic Compounds
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
441-463
Author(s):
Michel Demeule, Jonathan Michaud-Levesque, Borhane Annabi, Denis Gingras, Dominique Boivin, Julie jodoin, Sylvie Lamy, Yanick Bertrand and Richard Beliveau
Viral-Mediated Gene Transfer for Cancer Treatment
Journal:
Current Pharmaceutical Biotechnology
Volume:
3
Page:
151-164
Author(s):
Deborah R. Wilson
Catechol-O-Methyltransferase (COMT)-Mediated Methylation Metabolism of Endogenous Bioactive Catechols and Modulation by Endobiotics and Xenobiotics: Importance in Pathophysiology and Pathogenesis
Journal:
Current Drug Metabolism
Volume:
3
Page:
321-349
Author(s):
Bao Ting Zhu
Adenoviral Vectors for Cancer Gene Therapy
Journal:
Current Genomics
Volume:
3
Page:
163-180
Author(s):
Wenli Zhao, Masanobu Kobayashi, Masuo Hosokawa and Prem Seth
Mutant Epidermal Growth Factor Receptors as Targets for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
91-102
Author(s):
I. A.J. Lorimer